Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-packMarket Watch • 08/20/19
Teva's stock tumbles toward 20-year low; Moody's turns negative on drugmaker's 'junk'-rated debtMarket Watch • 08/14/19
Teva Pharmaceutical Industries Limited (TEVA) CEO Kare Schultz on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19